Business Crimes Hotline
Tyco Resolves DOJ and SEC FCPA Enforcement Action On Sept. 24, Tyco International Ltd. (Tyco) resolved enforcement actions by the DOJ and the SEC for alleged violations of the FCPA. Fines and penalties totaled over $26 million ($13.68 in the DOJ enforcement action and over $13 million in the SEC enforcement action). As part of the resolution, Tyco Valves & Controls Middle East Inc. (TVC ME), an indirect wholly owned subsidiary of Tyco, plead guilty before…
Features
Tax Considerations of FCPA Violations
Last month, the authors began examination of some of the tax consequences of violations of the FCPA. They continue with that discussion herein, with a look at civil penalties.
New Legal Risks
The authors analyze the "Petri dish of anger" against the financial services sector.
Difficult Issues: Indemnification and Fee-Advancement
Once an investigation or major lawsuit starts up, corporate personnel are sure to be involved and, consequently, the difficult issues surrounding indemnification and advancement will undoubtedly arise.
Features
Circuit Clarifies Parent Defense Under the Child Abduction Law
The one-year period that must expire before a parent in an international custody dispute can raise the defense that a child is settled in his or her new country cannot be equitably tolled, the Second U.S. Circuit Court of Appeals ruled on Oct. 1.
Consumers Allege Pulp Fiction in Tropicana's 'Natural' Claims
A look at a recent suit involving Tropicana orange juice advertising claims.
Features
Practice Tip: Undoing Pliva Inc. v. Mensing
Congress is discussing taking away generic drug manufacturers' labeling litigation shield.
Features
The PPACA 's 'Physician Payment Sunshine Provisions'
The U.S. Supreme Court's decision upholding the Patient Protection and Affordable Care Act (PPACA) may be one of the most controversial and talked-about legal decisions. But one of the most contested provisions of the Act ' a mandate known as the "Physician Payment Sunshine provisions" may have larger implications for pharmaceutical companies and others.
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- Strategy vs. Tactics: Two Sides of a Difficult CoinWith each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.Read More ›
- Major Differences In UK, U.S. Copyright LawsThis article highlights how copyright law in the United Kingdom differs from U.S. copyright law, and points out differences that may be crucial to entertainment and media businesses familiar with U.S law that are interested in operating in the United Kingdom or under UK law. The article also briefly addresses contrasts in UK and U.S. trademark law.Read More ›
- COVID-19: Economic Stimulus and SBA LoansA summary of information on the various provisions under the new federal economic stimulus package.Read More ›
- Strategic Uses of a Rule 2004 ExamWhile most bankruptcy practitioners are familiar with the basic concepts behind the Rule 2004 exam, some are less familiar with the procedural intricacies of obtaining, conducting, and responding to the exam ' intricacies that often involve practices and procedures adapted from civil discovery that are beyond the scope of pure bankruptcy practice. This article explains.Read More ›